Adrenal incidentalomas and arterial hypertension

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the last decades, the prevalence of arterial hypertension, a well-established cardiovascular risk factor, in the general population has substantially been increased. The same holds true for ''adrenal incidentalomas'' (AI), inapparent adrenal masses detected in approximately 5-10% of patients undergoing imaging of the abdomen for non-adrenal-related diseases. Once excluding the possibility of adrenal lesions being malignant, the clinician has to identify the subgroup of AI that exhibit autonomy of cortisol, aldosterone, or catecholamine secretion, states that are all associated with the development of hypertension. As these entities are usually found in the subclinical form, their clinical signi fi cance is not precisely known, and the followup and proper management of such patients has not been exactly clari fi ed. In this chapter we attempt to delineate the relation between arterial hypertension and subclinical states of hormone overproduction in AI, such as subclinical Cushing's syndrome, autonomous aldosterone secretion, silent pheochromocytomas, and apparently nonfunctioning lesions. The detailed diagnostic and therapeutic algorithms of the separate overt syndromes are presented in the relevant chapters.

Cite

CITATION STYLE

APA

Pappa, T., Kaltsas, G., Piaditis, G., & Chrousos, G. P. (2013). Adrenal incidentalomas and arterial hypertension. In Endocrine Hypertension: Underlying Mechanisms and Therapy (pp. 107–121). Humana Press Inc. https://doi.org/10.1007/978-1-60761-548-4_6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free